Correlation Between Korean Drug and Korea Steel

Can any of the company-specific risk be diversified away by investing in both Korean Drug and Korea Steel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korean Drug and Korea Steel into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Korean Drug Co and Korea Steel Co, you can compare the effects of market volatilities on Korean Drug and Korea Steel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korean Drug with a short position of Korea Steel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korean Drug and Korea Steel.

Diversification Opportunities for Korean Drug and Korea Steel

0.72

Correlation Coefficient

Korean Drug  Korea Steel

Poor diversification

The 3 months correlation between Korean and Korea is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and Korea Steel Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Korea Steel and Korean Drug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korean Drug Co are associated (or correlated) with Korea Steel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Korea Steel has no effect on the direction of Korean Drug i.e., Korean Drug and Korea Steel go up and down completely randomly.

Pair Corralation between Korean Drug and Korea Steel

Assuming the 90 days trading horizon Korean Drug Co is expected to under-perform the Korea Steel. But the stock apears to be less risky and, when comparing its historical volatility, Korean Drug Co is 1.02 times less risky than Korea Steel. The stock trades about -0.03 of its potential returns per unit of risk. The Korea Steel Co is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  152,400  in Korea Steel Co on September 27, 2024 and sell it today you would earn a total of  16,400  from holding Korea Steel Co or generate 10.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.39%
Values	Daily Returns

Korean Drug Co  vs.  Korea Steel Co

Korean Drug

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Korean Drug Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Korean Drug is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Korea Steel

Risk-Adjusted Performance

6 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Korea Steel Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Korea Steel may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Korean Drug and Korea Steel

The main advantage of trading using opposite Korean Drug and Korea Steel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korean Drug position performs unexpectedly, Korea Steel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korea Steel will offset losses from the drop in Korea Steel's long position.

The idea behind Korean Drug Co and Korea Steel Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.